Pharmacyclics LLC - Company Profile
Powered by 
All the sales intelligence you need on Pharmacyclics LLC in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pharmacyclics LLC fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pharmacyclics LLC.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Pharmacyclics LLC (Pharmacyclics), a subsidiary of AbbVie Inc, is a biopharmaceutical company which focuses on the development and commercialization of small-molecule medicines for the treatment of cancer and immune-mediated diseases. The company’s marketed product includes Imbruvica is an once-daily, first-in-class bruton's tyrosine kinase (BTK) inhibitor developed for the treatment of patients with chronic lymphocytic leukemia, waldenstrom's macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma and chronic graft-versus-host disease. Its products candidate in clinical development includes Imbruvica BTK inhibitor intended for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, diffuse large b-cell lymphoma, follicular lymphoma, graft versus host disease, mature B-cell non-hodgkin lymphomas and solid tumors, among others. Pharmacyclics is headquartered in Sunnyvale, California, the US..
Pharmacyclics LLC premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Marketed | Pharmacyclics |
| Imbruvica (ibrutinib): | Imbruvica |
| Chronic Lymphocytic Leukemia | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Pharmacyclics LLC | Pharming Group NV | CTI BioPharma Corp (Inactive) | Ambrilia Biopharma Inc | Aphios Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | Netherlands | United States of America | Canada | United States of America |
| City | Sunnyvale | Leiden | Waltham | Montreal | North Reading |
| State/Province | California | Zuid-Holland | Massachusetts | Quebec | Massachusetts |
| No. of Employees | - | 407 | 128 | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Angelina Wong | Associate Director - Drug Product, Process and Equipment Engineering | Senior Management | - | - |
| Stefan Geldmeyer | Head - Finance and Infrastructure | Senior Management | 2016 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer